Barry Greene

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is taking on a broad list of indications with RNAi therapeutics, from bleeding disorders to hypercholesterolemia to amyloidosis. “We’re really building a company that can emerge as a top five biotech company over the next five or so years,...